LASP1 and non-small cell lung carcinoma: MiR-29a functioned as an inhibition role in NSCLC via negatively modulating expression of LASP1 [50] and CDC42 [51], LASP1 functioned as a cAMP- and cGMP-dependent signaling protein and CDC42 was a protein involved in the adjustment of the cell cycle.